A settlement of as much as $220 million for Missouri consumers of the painkiller Vioxx won final approval Friday.
In November, Merck & Co. Inc. settled on the eve of trial a class-action lawsuit about its marketing of the drug in Missouri. It agreed to make an initial payment of $39 million into a common fund.
Of that, $30.5 million in fees and $2.4 million in expenses will go to the plaintiffs ...
↧